NEUERE "PYO" WIRKSAME BETALAKTAM-ANTIBIOTIKA = NOUVEAUX ANTIBIOTIQUES-BETALACTAMINIQUES ACTIFS SUR LE PYOCYANIQUEBAUERNFEIND A.1979; MUENCH. MED. WSCHR.; DEU; DA. 1979; VOL. 121; NO 3; PP. 107-108; ABS. ENG; BIBL. 5 REF.Article

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacinBAUERNFEIND, A.Journal of antimicrobial chemotherapy (Print). 1997, Vol 40, Num 5, pp 639-651, issn 0305-7453Article

SUGGESTED PROCEDURE ALLOWING USE OF PLASTIE PETRI DISHES IN BACTERIOCIN TYPING.BAUERNFEIND A; BURROWS JR.1978; APPL. ENVIRONMENT. MICROBIOL.; U.S.A.; DA. 1978; VOL. 35; NO 5; PP. 970; BIBL. 3 REF.Article

Bactericidal activity of antibiotics alone and in combination against enterococcus faecalis in a pharmacodynamic modelBAUERNFEIND, A.Clinical infectious diseases. 1992, Vol 15, Num 3, pp 481-485Article

SIMULTANEOUS SIMULATION OF THE SERUM PROFILES OF TWO ANTIBIOTICS AND ANALYSIS OF THE COMBINED EFFECT AGAINST A CULTURE OF PSEUDOMONAS AERUGINOSABAUERNFEIND A; JUNGWIRTH R; PETERMUELLER C et al.1982; CHEMOTHERAPY (BASEL); ISSN 0009-3157; CHE; DA. 1982; VOL. 28; NO 5; PP. 334-340; BIBL. 11 REF.Article

GRENZEN DER TETRAZYKLINTHERAPIE BEI INFEKTIONEN DES VAGINALBEREICHES. = LES LIMITES DE LA THERAPEUTIQUE TETRACYCLINIQUE DANS LES INFECTIONS DE LA REGION VAGINALEBAUERNFEIND A; BURROWS J; PETERMULLER C et al.1977; GEBURTSH. FRAUENHEILKDE; DTSCH.; DA. 1977; VOL. 37; NO 9; PP. 788-792; ABS. ANGL.; BIBL. 16 REF.Article

INACTIVATION OF CEPHALOSPORINS BY BETA-LACTAMASES OF GRAM-NEGATIVE RODSBAUERNFEIND A; PETERMULLER C; JUNGWIRTH R et al.1983; INFECTION; ISSN 0300-8126; DEU; DA. 1983; VOL. 11; SUPPL. 1; PP. 39-43; BIBL. 23 REF.Article

Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxilBAUERNFEIND, A; JUNGWIRTH, R.Infection. 1991, Vol 19, Num 5, pp 353-362, issn 0300-8126Article

Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporinsBAUERNFEIND, A; HÖRL, G.Infection. 1987, Vol 15, Num 4, pp 257-259, issn 0300-8126Article

Typing of Enterobacter spp. by bacteriocin susceptibility and its use in epidemiological analysisBAUERNFEIND, A; PETERMÜLLER, C.Journal of clinical microbiology (Print). 1984, Vol 20, Num 1, pp 70-73, issn 0095-1137Article

Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCRBAUERNFEIND, A; SCHNEIDER, I; JUNGWIRTH, R et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 9, pp 2748-2751, issn 0095-1137Article

Characterization of the plasmidic β-lactamase CMY-2 which is responsible for cephamycin resistanceBAUERNFEIND, A; STEMPLINGER, I; JUNGWIRTH, R et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 1, pp 221-224, issn 0066-4804Article

Teicoplanin in the therapy of bone and joint infectionsEITEL, F; BAUERNFEIND, A; LANG, E et al.Current therapeutic research. 1992, Vol 51, Num 1, pp 97-111, issn 0011-393XArticle

Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCRBAUERNFEIND, A; SCHNEIDER, I; JUNGWIRTH, R et al.Journal of clinical microbiology (Print). 1999, Vol 37, Num 5, pp 1335-1339, issn 0095-1137Article

Processing raw absorbance data generated by ELISA for measuring specific antibody activitySTEIMER, W; PRZYKLENK, B; BAUERNFEIND, A et al.Serodiagnosis and immunotherapy in infectious disease. 1993, Vol 5, Num 1, pp 53-59, issn 0888-0786Article

Häufigkeit und Antibiotikaempfindlichkeit von Oxacillin-resistenten Staphylococcus aureus-Stämmen in einem Lehrkrankenhaus = Frequency and antimicrobial susceptibility of oxacillin-resistant staphylococcus aureus in a teaching hospitalRITTER, E; BAUERNFEIND, A; DORITTKE, C et al.Zentralblatt für Hygiene und Umweltmedizin. 1998, Vol 201, Num 3, pp 285-296, issn 0934-8859Article

Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycinsBAUERNFEIND, A; CHONG, Y; SCHWEIGHART, S et al.Infection. 1989, Vol 17, Num 5, pp 316-321, issn 0300-8126Article

Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogensBAUERNFEIND, A; JUNGWIRTH, R; EBERLEIN, E et al.Infection. 1995, Vol 23, Num 5, pp 316-321, issn 0300-8126Article

A novel class c β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycinsBAUERNFEIND, A; WAGNER, S; JUNGWIRTH, R et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 9, pp 2041-2046, issn 0066-4804Article

Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patientsBAUERNFEIND, A; ROSENTHAL, E; EBERLEIN, E et al.Infection. 1993, Vol 21, Num 1, pp 18-22, issn 0300-8126Article

Zum Einfluss von Sulbactam aud die In-vitro-Aktivität von Mezlocillin, Piperacillin und Cefotaxim = Impact of sulbactam on the in-vitro-activity activity of Mezlocillin, Piperacillin and CefotaximBAUERNFEIND, A; GRIMM, H; KLIETMANN, W et al.Arzneimittel-Forschung. 1991, Vol 41, Num 8, pp 831-838, issn 0004-4172Article

Staphylococcus aureus in patients with cystic fibrosis : an epidemiological analysis using a combination of traditional and molecular methodsGOERING, R. V; BAUERNFEIND, A; LENZ, W et al.Infection. 1990, Vol 18, Num 1, pp 57-60, issn 0300-8126Article

A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumoniaBAUERNFEIND, A; SCHNEIDER, I; JUNGWIRTH, R et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 8, pp 1924-1931, issn 0066-4804Article

Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals : Identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamasesGNIADKOWSKI, M; SCHNEIDER, I; JUNGWIRTH, R et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 3, pp 514-520, issn 0066-4804Article

Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomalleiBAUERNFEIND, A; ROLLER, C; MEYER, D et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 9, pp 2737-2741, issn 0095-1137Article